| 116.79 Delayed Data As of May 24 |  -0.02 / -0.02%Today’s Change | 81.65 Today|||52-Week Range 132.13 | +0.92% Year-to-Date |
| Previous close | 116.81 |
| Today’s open | 117.53 |
| Day’s range | 116.45 - 117.55 |
| Volume | 2,086,492 |
| Average volume (3 months) | 13,116,278 |
| Market cap | $113.4B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +1.41% |
| Earnings growth (next 5 years) | +8.40% |
| Revenue growth (last year) | +7.36% |
| P/E ratio | 45.1 |
| Price/Sales | 4.87 |
| Price/Book | 12.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -1.09 | -1.34% |
| SNYSanofi | +0.17 | +0.40% |
| GSKGlaxoSmithKline | +0.19 | +0.48% |
| AZNAstraZeneca | +0.36 | +0.93% |
| Next reporting date | July 30, 2019 |
| EPS forecast (this quarter) | $1.44 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 13.16% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chairman, President & Chief Executive Officer David A. Ricks |
Senior VP & President-Manufacturing Operations Myles Oneill |
Corporate headquarters Indianapolis, Indiana |
